Top news of the week: 15.09.2020.

#biospace #biotechnology #vaccine #coronavirus #lifesciences #pharmaceuticals #treatment #COVID19 #COVID #pandemic

Companies And Industries

On Sep 9, 2020
@biospace shared
Biopharma Update on the Novel Coronavirus: September 9 #biospace #lifesciences #biotechnology #pharmaceuticals #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine https://t.co/PVAHOh8HKR
Open

Biopharma Update on the Novel Coronavirus: September 9

Biopharma Update on the Novel Coronavirus: September 9

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 9, 2020.

On Sep 9, 2020
@biospace shared
An Overview of Citi’s 15th Annual BioPharma Conference 2020 Boston #biospace #lifesciences #biotechnology #pharmaceuticals https://t.co/GrSccL72dx
Open

An Overview of Citi’s 15th Annual BioPharma Conference 2020 Boston

An Overview of Citi’s 15th Annual BioPharma Conference 2020 Boston

Like almost all conferences this year, Citi’s 15th Annual BioPharma Conference 2020 is being held virtually.

On Sep 9, 2020
@BioWorld shared
Asian region carves larger piece of biopharma deal pie in 2020 https://t.co/kD1Ea31ion
Open

Asian region carves larger piece of biopharma deal pie in 2020

Asian region carves larger piece of biopharma deal pie in 2020

As biopharma deal values continue to rise above recent years, a growing percentage of the funds are coming through partnerships with companies headquartered in Asia and nearby countries. ...

On Sep 11, 2020
@matthewherper shared
Listen: AstraZeneca’s Covid-19 vaccine problem, charged coronavirus politics, and #STATHealthTech! https://t.co/tPOS2raIkY
Open

Listen: AstraZeneca’s Covid-19 vaccine problem, charged coronavirus politics, and a recap of STAT’s Health Tech Summit

Listen: AstraZeneca’s Covid-19 vaccine problem, charged coronavirus politics, and a recap of STAT’s Health Tech Summit

In this episode, we'll break down the big news of the week: the global pause on AstraZeneca’s Phase 3 trials of its Covid-19 vaccine.

On Sep 9, 2020
@CellCultureDish shared
Best Practices for Successful Technology Transfer https://t.co/WZcpQToV3L
Open

Best Practices for Successful Technology Transfer

Best Practices for Successful Technology Transfer

Technology transfer is a critical aspect of moving a biologic from discovery to commercial manufacturing. Ideally, there is a clear plan for technology transfer that results in a successful ...

On Sep 10, 2020
@BioWorld shared
A knight at the OPERA? Kraken the RNA code, Korro on (r)ADAR with $91.5M series A https://t.co/Agp3UHaJej
Open

A knight at the OPERA? Kraken the RNA code, Korro on (r)ADAR with $91.5M series A

A knight at the OPERA? Kraken the RNA code, Korro on (r)ADAR with $91.5M series A

Nessan Bermingham, Korro Bio Inc.’s co-founder and executive chair, told BioWorld that other groups are looking into adenosine deaminase acting on RNA (ADAR) – the body’s natural base ...

On Sep 9, 2020
@LabRoots shared
New products and support services are providing the critical tools and components which enable clinicians to detect specific biomarkers and target treatments, resulting in better patient outcomes. Find out more at Cytiva's diagnostics virtual summit https://t.co/We8ZYUnRM3 https://t.co/hQXKDCdwPB
Open

Diagnostics Virtual Summit (A global perspective)

Diagnostics Virtual Summit (A global perspective)

Each step in a diagnostic test’s journey—from raw material extraction to patient administration—can influence outcomes. Advances in molecular biology, immunodiagnostics and

On Sep 14, 2020
@IAmBiotech shared
U.S., European #coronavirus #vaccine developers pledge to make safety the main focus in vaccine development https://t.co/fQqVCXBiTp
Open

U.S., European drugmakers pledge to make safety the main focus in coronavirus vaccine development

U.S., European drugmakers pledge to make safety the main focus in coronavirus vaccine development

The CEOs of nine major drugmakers announced Tuesday that they have pledged to make the safety and well-being of vaccinated individuals their main priority in the development of vaccines to ...